KYTX Next Earnings Date Notes

— Kyverna Therapeutics (KYTX) is a clinical-stage biopharmaceutical company focused on developing innovative & accessible cell therapies for patients with autoimmune diseases. Leveraging its cellular engineering platform, Kyverna aims to bring novel CAR T-cell therapies—specifically KYV-101 & KYV-201—into the clinic, targeting indications such as lupus nephritis, multiple sclerosis, and other serious autoimmune conditions with significant unmet need. As you prepare for the next KYTX earnings call, the most relevant business metrics to track include: progress & updates on pipeline programs (notably enrollment milestones in Phase 1/2 clinical trials and any early efficacy/safety data), the cash runway (measuring how long current funds will support operations), R&D expenditure (reflecting pipeline advancement), & strategic partnership or licensing developments. Since commercial revenues are likely years away, Kyverna's valuation hinges on clinical progress, robust IP portfolio, and management's ability to articulate near-term inflection points. Listen for management insights regarding trial timelines, regulatory feedback, and plans for expanding the pipeline or entering new markets, as these factors will be key drivers of long-term shareholder value. The next projected earnings date for KYTX is 8/11/2026 after close (stay tuned for a confirmed earnings date once announced).

KYTX Next Earnings Date FAQ

On this page we presented the KYTX Next Earnings Date information for Kyverna Therapeutics along with recent past earnings dates. For Q1 of 2026, KYTX reported earnings of -0.660/share, with the earnings report taking place on 5/12/2026. For Q4 of 2025, KYTX reported earnings of -0.800/share, with the earnings report taking place on 3/26/2026. For Q3 of 2025, KYTX reported earnings of -0.850/share, with the earnings report taking place on 11/12/2025. For Q2 of 2025, KYTX reported earnings of -0.970/share, with the earnings report taking place on 8/12/2025. For Q1 of 2025, KYTX reported earnings of -1.030/share, with the earnings report taking place on 5/13/2025. Based on these past earnings dates, the projected next earnings date for KYTX is 8/11/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Kyverna Therapeutics. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Kyverna Therapeutics shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Kyverna Therapeutics next earnings dates as well as any other stock out there in our coverage universe, to see when the next KYTX earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up KYTX's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the KYTX next earnings date.